Novavax (NVAX) Stock Is a Winner, But How Much Higher Can It Go?
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
AstraZeneca may consider exposing vaccine trial participants to virus
Cincinnati children’s HLH research points to treatment for COVID-19 cytokine storms
PKU-led team found effective SARS-CoV-2 neutralizing antibodies
GSK to produce a billion doses of COVID-19 vaccine booster by 2021
ABPI’s Sheuli Porkess on how COVID-19 could improve clinical trial conduct
Vaxine and Medytox – COVAX-19®
France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
Merck & Co and IAVI join forces to develop COVID-19 vaccine
Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
Merck Takes 3 Major Shots at COVID-19
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
Gilead Still Holds the Winning Hand, Says 5-Star Analyst
Inovio Pops Almost 10% on ‘Positive’ Preclinical Results For Its Covid-19 Vaccine
Prellis Bio’s Externalized Human Immune System rapidly generates 300 SARS-CoV2 antibodies
Moderna stock volatile amid work on coronavirus vaccine
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
COVID-19 prevention trial opens for high-risk healthcare workers
Dynavax Explodes 40% In Pre-Market On Phase 1 Covid-19 Vaccine News
X-ray experiments zero in on COVID-19 antibodies
Global study to test malaria drug to protect health workers from COVID-19
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
‘Like looking for a needle in a haystack’: the global hunt to block COVID-19
AstraZeneca Aiming For 30M UK Covid-19 Vaccine Doses By September